{"id":3537,"date":"2016-07-13T11:04:58","date_gmt":"2016-07-13T15:04:58","guid":{"rendered":"https:\/\/medicarereport.org\/?p=3537"},"modified":"2016-07-13T11:04:58","modified_gmt":"2016-07-13T15:04:58","slug":"fda-lets-cancer-trial-resume-after-three-patient-deaths","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=3537","title":{"rendered":"FDA lets cancer trial resume after three patient deaths"},"content":{"rendered":"<p>(By Damian Garde for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">F<\/span>ederal regulators on Tuesday gave Juno Therapeutics the all-clear to\u00a0resume\u00a0testing an experimental cancer treatment, just days after <a href=\"https:\/\/www.statnews.com\/2016\/07\/07\/juno-cancer-immunotherapy-deaths\/\" target=\"_blank\">shutting down the trial<\/a> because of three patient deaths. <a href=\"https:\/\/www.statnews.com\/2016\/07\/12\/fda-juno-resume-cancer-trial\/?_hsenc=p2ANqtz--N26opX3Wj4O6hw5b4FrFq8HT9flV3rFLoSbtSwAWuvuGe8nO4H75KSCZqHZg16VOTea-lUwPxgeKmiEhRhbtqM8S0GQ&amp;_hsmi=31603492\" target=\"_blank\">Read article here&#8230;.<\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Damian Garde for STAT) Federal regulators on Tuesday gave Juno Therapeutics the all-clear to\u00a0resume\u00a0testing an experimental cancer treatment, just<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,15],"tags":[],"class_list":["post-3537","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3537"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3537\/revisions"}],"predecessor-version":[{"id":3538,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3537\/revisions\/3538"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}